Trial | NCT04124913  Report issue

Title

Oral Dydrogesterone vs. Micronized Vaginal Progesterone for Luteal Phase Support in Frozen-thawed Embryo Transfer Cycles
Comparison of Oral Dydrogesterone Versus Micronized Vaginal Progesterone for Luteal Phase Support in Frozen-thawed Embryo Transfer Cycles: a Randomized Controlled Trial

  • Phase

    Phase 4

  • Study Type

    Interventional

  • Status

    Unknown status

  • Study Participants

    140
The aim of this randomized controlled trial is to compare the efficacy of oral dydrogesterone vs. micronized vaginal progesterone for luteal phase support in frozen-thawed embryo transfer cycles.
Study Started
Jan 02
2019
Primary Completion
Oct 31
2019
Anticipated
Study Completion
Dec 31
2019
Anticipated
Last Update
Oct 14
2019

Drug Dydrogesterone 10 MG Oral Tablet

Oral dydrogesterone 10 mg tablet three times a day for luteal phase support

  • Other names: Duphaston

Drug Progesterone Vaginal Gel [Crinone]

Vaginal progesterone gel 90 mg once a day for luteal phase support

  • Other names: Crinone %8 vaginal progesterone gel

Dydrogesterone Experimental

Vaginal progesterone Active Comparator

Criteria 

Inclusion Criteria:

Ages between 20 and 40
Modified natural frozen- thawed embryo transfer cycles

Exclusion Criteria:

Recurrent implantation failure
Recurrent pregnancy loss
Presence of uterine pathology
No Results Posted